Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$15,000.00
Apr 2, 2024
For-profit organization
Develop digital adoption plan
$15,000.00
Apr 2, 2024
For-profit organization
Develop digital adoption plan
$14,000.00
Apr 1, 2024
For-profit organization
Work Experience
YESP2425-5132-PR
This project aims to provide a youth with some work experience in the agriculture and agri-food sector.
$14,000.00
Apr 1, 2024
For-profit organization
Work Experience
YESP2425-5118-PR
This project aims to provide a youth with some work experience in the agriculture and agri-food sector.
$1,154,425.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177577
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$226,399.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177569
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$2,050,829.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects
177551
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$3,461,062.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects
177555
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$59,583.00
Apr 1, 2024
Individual or sole proprietorship
Fellowship - Priority Announcement - HIV/AIDS and/or STBBI
177406
This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research
$1,597,256.00
Apr 1, 2024
Individual or sole proprietorship
Team Grant: Improving Health and Admin Data and Monitor Rare Diseases
178408
The specific objectives of this funding opportunity are to:
• Demonstrate the feasibility of tracking rare diseases and conducting prospective studies in this field within the Canadian health care systems;
• Increase cross-jurisdictional collaboration and data sharing amongst hospitals;
• Prospectively assess the impact of mortality, co-morbidities, hospital usage, other health system usage, and total direct cost of rare diseases to the health care system; and,
• Facilitate the establishment of patient registries for potential enrollment by a diversity of people in Canada in clinical trials and to enable patient and caregiver peer-to-peer contact.